Overview
Ceylon Tobacco Company is Sri Lanka’s dominant cigarette manufacturer, spanning leaf sourcing to islandwide distribution with some exports. It is a cash generative, capital-light franchise whose appeal rests on resilient margins and consistent dividends. With a market capitalisation of LKR 337.1 billion, it remains one of the CSE’s heavyweight consumer names. Strategy appears steady: protect share in key brands, price through tax cycles, and return surplus cash. Leadership transitioned in 2026 with a new CEO taking office, and board committees refreshed, suggesting continuity under the BAT Group umbrella. The main operational question into 2026 is whether rising finance and tax charges below the line continue to offset operating gains and leave bottom-line progress muted.
Price performance
CTC has outpaced the market over the past year, gaining 22.4% while the broader ASPI rose more modestly. Momentum has cooled recently, with a -1.4% 3-month return and a flat 1-month print. The share trades near the top of its 52-week range at LKR 1,835 to 1,500. Liquidity is typically thin, with 1,242 shares trading on an average day, and the stock shows lower index co-movement, with a 0.63 beta to the ASPI. The upshot is a name that can diverge from the index and gap on low volume, especially around dividend dates and regulatory headlines.
Valuation
CTC trades on an 11.56 P/E, a shade below the sector median 12.51, despite cash flows that are steadier than most consumer names. Its 26.66 P/B looks extreme in isolation but is largely a function of its capital-light model and outsized profitability: reported ROE is 263.7%. The dividend proposition remains central, with an indicated 8.8% yield and a 101.2% payout, implying roughly 1x dividend cover and limited balance sheet accretion by design. For income-oriented investors that mix is attractive; for re-rating seekers, multiple expansion may be capped unless earnings re-accelerate.
News and sentiment
News flow has been active and broadly constructive in the past quarter. We tracked 7 material items, of which 5 were positive and 1 negative. Governance refreshed with a new Managing Director and CEO effective 1 May 2026. Cash returns continued, with a first interim dividend of LKR 34 per share going ex on 21 May 2026. A Finance Director appointment from the BAT Group further strengthens the bench. Overall tone is stable: management transitions look orderly, and the dividend cadence remains intact.
Financials
CTC’s latest filed quarter to 31 March 2026 delivered another high-margin print. Gross margin was 94.4% versus 96.6% a year earlier; operating margin 79.2% versus 80.4%; and net margin 41.7% versus 47.2%. Revenue and operating profit grew year-on-year, but net profit was essentially flat as higher finance, tax and other below-the-line charges absorbed much of the operating uplift. For the full year to 31 December 2025, margins also remained elevated and revenue expanded modestly, while net profit edged lower year-on-year. There were no indications in the news flow of results released after March, so these are the freshest financials available in filings.
Risks
Key risks are largely extrinsic. Tobacco is highly regulated, and excise decisions can change pricing points and volumes quickly; illicit trade pressure can intensify if affordability is squeezed. The payout policy leaves little buffer for balance sheet build, so any shock to cash conversion would test dividend sustainability. Liquidity is thin and episodes of one-way order flow can move the price. Macro adds noise: July inflation printed 7.3%, and the rupee has hovered around 335 to 336 per US dollar in recent weeks, factors that can influence both consumer purchasing power and the timing of fiscal measures. Export-facing processes also face tighter sustainability compliance timelines.
Outlook
Near term, watch whether net margin holds at or above 41.7% as excise and mix flow through; that would signal pricing power remains intact. A visible reduction in below-the-line charges would allow operating gains to translate to bottom-line growth again. On capital returns, the litmus test for FY2026 is whether aggregate DPS stays broadly aligned with EPS of LKR 156 without stretching the balance sheet. Leadership changes appear to be bedding in smoothly; evidence of stable volume share in core brands alongside steady cash conversion would support sentiment, while a surprise tax step-up or a slip in margins would likely cap the shares.